Loading...
Please wait, while we are loading the content...
Similar Documents
Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb $761^{®}$)
| Content Provider | MDPI |
|---|---|
| Author | Tomino, Carlo Ilari, Sara Solfrizzi, Vincenzo Malafoglia, Valentina Zilio, Guglielmo Russo, Patrizia Proietti, Stefania Marcolongo, Federica Scapagnini, Giovanni Muscoli, Carolina Rossini, Paolo |
| Copyright Year | 2021 |
| Description | Mild cognitive impairment (MCI) and dementia are clinically prevalent in the elderly. There is a high risk of cognitive decline in patients diagnosed with MCI or dementia. This review describes the effectiveness of Ginkgo biloba leaf special extract EGb 761® for the treatment of dementia syndromes and EGb 761® combination therapy with other medications for symptomatic dementia. This drug has shown convincing results, improving cognitive function, neuropsychiatric symptoms and consequent reduction of caregiver stress and maintenance of autonomy in patients with age-related cognitive decline, MCI and mild to moderate dementia. Currently, there is little evidence to support the combination therapy with anti-dementia drugs and, therefore, more evidence is needed to evaluate the role of EGb 761® in mixed therapy. |
| Starting Page | 305 |
| e-ISSN | 14248247 |
| DOI | 10.3390/ph14040305 |
| Journal | Pharmaceuticals |
| Issue Number | 4 |
| Volume Number | 14 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2021-04-01 |
| Access Restriction | Open |
| Subject Keyword | Pharmaceuticals Integrative and Complementary Medicine Mild Cognitive Impairment (mci) Mild Dementia Alzheimer's Disease Ginkgo Biloba (egb761®) Tebonin Anti-dementia Drugs Randomized Controlled Trials |
| Content Type | Text |
| Resource Type | Article |